| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |